Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial

Kearon, 2012, Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e419S, 10.1378/chest.11-2301

van Es, 2014, Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials, Blood, 124, 1968, 10.1182/blood-2014-04-571232

Kahn, 2006, The post-thrombotic syndrome: progress and pitfalls, Br J Haematol, 134, 357, 10.1111/j.1365-2141.2006.06200.x

Prandoni, 2009, Post-thrombotic syndrome: prevalence, prognostication and need for progress, Br J Haematol, 145, 286, 10.1111/j.1365-2141.2009.07601.x

Enden, 2013, Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study, BMJ Open, 3, e002984, 10.1136/bmjopen-2013-002984

Schulman, 2006, Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months, J Thromb Haemost, 4, 734, 10.1111/j.1538-7836.2006.01795.x

Comerota, 2013, Thrombolysis for iliofemoral deep venous thrombosis, Expert Rev Cardiovasc Ther, 11, 1631, 10.1586/14779072.2013.852955

Watson, 2014, Thrombolysis for acute deep vein thrombosis, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD002783.pub3

Haig, 2014, Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis, J Vasc Surg Venous Lymphat Disord, 2, 123, 10.1016/j.jvsv.2013.10.054

Enden, 2012, Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial, Lancet, 379, 31, 10.1016/S0140-6736(11)61753-4

Enden, 2013, Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis, J Thromb Haemost, 11, 1032, 10.1111/jth.12184

Enden, 2007, Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis—the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771), Am Heart J, 154, 808, 10.1016/j.ahj.2007.07.010

Buller, 2004, Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 401S, 10.1378/chest.126.3_suppl.401S

Haig, 2013, Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis, J Vasc Interv Radiol, 24, 17, 10.1016/j.jvir.2012.09.023

Villalta, 1994, Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome, Haemostasis, 24, 158

Kahn, 2009, Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization, J Thromb Haemost, 7, 879, 10.1111/j.1538-7836.2009.03294.x

Enden, 2009, Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire, Scand J Caring Sci, 23, 369, 10.1111/j.1471-6712.2008.00618.x

Lamping, 2003, Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life, J Vasc Surg, 37, 410, 10.1067/mva.2003.152

Wittrup-Jensen, 2009, Generation of a Danish TTO value set for EQ-5D health states, Scand J Public Health, 37, 459, 10.1177/1403494809105287

Walters, 2005, Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D, Qual Life Res, 14, 1523, 10.1007/s11136-004-7713-0

Kahn, 2014, Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial, Lancet, 383, 880, 10.1016/S0140-6736(13)61902-9

Vedantham, 2013, Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis, Am Heart J, 165, 523, 10.1016/j.ahj.2013.01.024

Hofmann, 2012, Catheter-directed thrombolysis for acute DVT, Lancet, 379, 3, 10.1016/S0140-6736(11)61875-8

Husmann, 2007, Stenting of common iliac vein obstructions combined with regional thrombolysis and thrombectomy in acute deep vein thrombosis, Eur J Vasc Endovasc Surg, 34, 87, 10.1016/j.ejvs.2007.01.006

Kahn, 2008, Determinants of health-related quality of life during the 2 years following deep vein thrombosis, J Thromb Haemost, 6, 1105, 10.1111/j.1538-7836.2008.03002.x

Ghanima, 2011, Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis, J Thromb Haemost, 9, 1261, 10.1111/j.1538-7836.2011.04298.x

Kahn, 2005, Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis, J Thromb Haemost, 3, 718, 10.1111/j.1538-7836.2005.01216.x

van Dongen, 2005, Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome, J Thromb Haemost, 3, 939, 10.1111/j.1538-7836.2005.01333.x

Vedantham, 2009, Reporting standards for endovascular treatment of lower extremity deep vein thrombosis, J Vasc Interv Radiol, 20, S391, 10.1016/j.jvir.2009.04.034

Soosainathan, 2013, Scoring systems for the post-thrombotic syndrome, J Vasc Surg, 57, 254, 10.1016/j.jvs.2012.09.011